Moreover, treatment of CRC cells with a FOXO1‐specific inhibitor (AS1842856) significantly suppressed the secretion of CX3CL1 (Figure S3I, Supporting Information). The gene discussed is CX3CL1; the disease is colorectal carcinoma.